ARTICLE SUMMARY:
An expert panel convened by MTS and Weill Cornell Medicine examined how hospitals, digital health innovators, medtech companies and investors are defining and benchmarking data value in real-world transactions and recommended frameworks for strengthening data-sharing agreements.
Panelists explored how health systems, researchers, and entrepreneurs can think realistically about the value of health data and discussed rights and consent, data ownership, real‑world deal structures (e.g., AI collaborations, consortia, internal tools), including a case study, and how investors distinguish between raw data and commercial products. The goal was to equip listeners with practical questions and frameworks for navigating this evolving space.
